IRIS
ANGELICO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 95.811
AS - Asia 9.226
EU - Europa 7.399
SA - Sud America 1.280
Continente sconosciuto - Info sul continente non disponibili 562
AF - Africa 126
OC - Oceania 18
Totale 114.422
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 95.266
SG - Singapore 4.291
CN - Cina 2.045
UA - Ucraina 1.223
DE - Germania 1.120
BR - Brasile 1.023
RU - Federazione Russa 1.015
HK - Hong Kong 889
IT - Italia 884
IE - Irlanda 764
VN - Vietnam 652
SE - Svezia 525
FI - Finlandia 473
FR - Francia 470
GB - Regno Unito 375
KR - Corea 340
BD - Bangladesh 252
CA - Canada 233
PL - Polonia 230
JP - Giappone 174
IN - India 164
AR - Argentina 69
MX - Messico 63
NL - Olanda 62
CO - Colombia 54
ID - Indonesia 51
TR - Turchia 48
EC - Ecuador 44
AT - Austria 43
BE - Belgio 43
IQ - Iraq 43
CR - Costa Rica 41
ES - Italia 38
ZA - Sudafrica 38
TT - Trinidad e Tobago 36
VE - Venezuela 33
PK - Pakistan 31
CW - ???statistics.table.value.countryCode.CW??? 29
CZ - Repubblica Ceca 27
NI - Nicaragua 26
IL - Israele 23
PR - Porto Rico 23
SV - El Salvador 23
CL - Cile 22
HN - Honduras 22
MY - Malesia 22
JM - Giamaica 21
UZ - Uzbekistan 20
AE - Emirati Arabi Uniti 19
GT - Guatemala 18
EG - Egitto 17
RO - Romania 17
NP - Nepal 16
AU - Australia 15
SA - Arabia Saudita 14
PY - Paraguay 13
LT - Lituania 12
TH - Thailandia 12
CH - Svizzera 11
GP - Guadalupe 11
JO - Giordania 11
PH - Filippine 11
IR - Iran 10
KZ - Kazakistan 10
MA - Marocco 10
TN - Tunisia 10
EE - Estonia 9
EU - Europa 9
KG - Kirghizistan 9
PE - Perù 9
UY - Uruguay 9
DZ - Algeria 8
ET - Etiopia 8
TW - Taiwan 8
MD - Moldavia 7
OM - Oman 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AZ - Azerbaigian 6
KE - Kenya 6
LK - Sri Lanka 6
PT - Portogallo 6
SC - Seychelles 6
AL - Albania 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
NG - Nigeria 5
SY - Repubblica araba siriana 5
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
GR - Grecia 4
HR - Croazia 4
KW - Kuwait 4
LB - Libano 4
MN - Mongolia 4
PS - Palestinian Territory 4
SN - Senegal 4
TM - Turkmenistan 4
AM - Armenia 3
BB - Barbados 3
Totale 113.834
Salva come PNG Salva come JPEG
Città #
Woodbridge 27.065
Wilmington 23.499
Houston 21.597
Fairfield 2.712
Ashburn 2.241
Singapore 2.042
Ann Arbor 1.967
San Jose 1.194
Jacksonville 1.140
Seattle 1.112
Chandler 1.070
Cambridge 909
Hong Kong 876
Beijing 759
Dublin 744
Medford 572
New York 545
Dearborn 516
Santa Clara 421
Council Bluffs 339
The Dalles 292
Rome 276
Lawrence 266
Los Angeles 259
Helsinki 220
Zhengzhou 203
Mülheim 190
Ho Chi Minh City 189
Kraków 174
Hanoi 172
Buffalo 164
Lauterbourg 153
Moscow 146
Hangzhou 138
San Diego 138
Tokyo 134
North Bergen 124
Menlo Park 121
São Paulo 118
Boardman 116
Dallas 111
Milan 109
Denver 97
Sunnyvale 90
Orem 82
Chicago 78
Atlanta 67
Shanghai 66
Phoenix 60
Munich 56
Palo Alto 53
London 52
University Park 52
San Francisco 50
Chennai 47
Frankfurt am Main 47
Warsaw 47
Brooklyn 46
Jersey City 46
Mountain View 46
Toronto 44
Columbus 43
Hefei 42
Norwalk 41
Falls Church 40
Montreal 38
Nuremberg 38
Redwood City 38
Brussels 36
Guangzhou 36
San Mateo 36
Detroit 35
Nanjing 35
Verona 34
Manchester 31
Stockholm 30
Johannesburg 29
Redondo Beach 29
Willemstad 29
Managua 26
San José 26
Rio de Janeiro 25
Kunming 23
Haiphong 22
Mexico City 22
Seoul 22
Philadelphia 21
Amsterdam 20
Indiana 20
Washington 20
Charlotte 18
Jakarta 18
Mumbai 17
Naples 17
Quito 17
Vienna 17
Baghdad 16
Belo Horizonte 16
Boston 16
Curitiba 16
Totale 97.314
Salva come PNG Salva come JPEG
Nome #
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.404
Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites 681
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 680
Hepatitis C reinfection after liver transplantation in relation to virus genotype 627
Boceprevir for untreated chronic HCV genotype 1 infection. 623
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 610
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression 599
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 595
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 571
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 558
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 540
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 530
Transport, utilization and biliary secretion of lysophosphatidylcholine in the rat liver 529
Recurrence of insulin resistant metabolic syndrome following liver transplantation 528
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 523
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 518
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 514
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 510
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 510
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 509
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 509
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 509
Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C 507
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 506
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 505
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia 502
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial 502
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 502
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 501
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease 500
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 499
A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy 498
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 498
Operational tolerance in clinical liver transplantation: emerging developments. 498
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 494
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 493
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 492
Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae 490
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 486
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 486
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 485
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development 485
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 484
Liver contrast enhanced ultrasound perfusion imaging in the evaluation of chronic hepatitis C fibrosis: preliminary results 484
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 483
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 482
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late 480
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 479
596 478
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 478
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 478
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 477
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 476
Leptin attenuates ischemia-reperfusion injury in the rat liver. 475
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 474
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis 470
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients 470
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha 469
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 469
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 468
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!". 468
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 468
Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort 468
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B 466
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 465
In vivo, high field, 3-Tesla H MR spectroscopic asessment of liver in fibrosis in HCV-correlated chronic liver disease Valutazione in vivo della fibrosi epatica in corso di epatopatia cronica HCV con spettroscopia H-RM 3T 464
Quasielastic light scattering evidence for vesicular secretion of biliary lipids 464
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 463
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 463
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat 462
Liver elasticity in NASH patients evaluated with real-time elastography (RTE). 462
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 462
Sequential changes in serum and biliary bile acids after liver transplantation 461
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 459
Effect of glucose and/or branched chain amino acid infusion on plasma amino acid imbalance in chronic liver failure 459
Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs 458
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 458
Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection 457
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 457
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 457
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 455
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 455
Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response 455
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 454
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 453
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 453
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 453
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 452
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation 452
High performance liquid chromatographic analysis of molecular species of phosphatidylcholine--development of quantitative assay and its application to human bile 452
A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? 451
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 450
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 448
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation 448
Biliary sludge: a critical update 446
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 445
Liver transplantation for end-stage liver disease related to viral hepatitis 445
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 445
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells 444
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 444
Totale 49.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 247.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 247.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.043 0 0 0 0 64 361 120 113 263 243 109 770
2022/20233.194 375 231 124 345 250 739 271 185 300 28 284 62
2023/2024862 134 21 85 20 91 215 14 22 11 23 7 219
2024/20256.063 186 1.289 617 335 113 475 294 227 538 378 864 747
2025/20269.712 736 431 1.020 905 840 547 1.238 1.437 986 808 434 330
2026/20275.332 656 810 2.153 1.404 309 0 0 0 0 0 0 0
Totale 114.422